Pharmaceutical Technology

SEPTEMBER 1, 2022

While a significant proportion of this increase is due to the volume of lateral flow tests (LFTs) manufactured to perform mass screening of populations for Covid-19 over the last two years, this trend towards POC diagnostics is positive news. We are not a start-up company for diagnostic device manufacturing,” remarks Bauer.

Manufacturing 130

Manufacturing Bacterium Reagent Production 130

pharmaphorum

JANUARY 18, 2022

“In 2021, digital health companies catalysing R&D in biopharma and medtech topped the chart with $5.8B ” The funding boom is good news for the sector but it does set up high expectations for 2022. “The past twelve months have taught us that when capital isn’t a constraint, execution is all that’s left.

Life Science 91

Life Science Clinical Trials Clinical Trials Trials 91

The Pharma Data

MAY 13, 2021

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. . Medtech. Communication, Cooperation, Harmonization: Experts Generate New EU Regulatory Momentum ( MedtechInsight ). Posted 13 May 2021 | By Michael Mezher . In Focus: US. Purdue’s Ch.

FDA Approval 52

FDA Approval Vaccination Vaccine Drugs 52

The Pharma Data

MAY 7, 2021

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. . Medtech. FDA’s Shuren: ‘Senior-Level Folks’ Will Take Part In New Inspectional Affairs Council ( MedtechInsight ). Posted 07 May 2021 | By Michael Mezher . In Focus: US. Generic Drug Cos.

Vaccination 52

Vaccination Vaccine Drugs Regulation 52

XTalks

DECEMBER 20, 2023

Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device. Read on to see our editorial team’s top news picks of the year.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

XTalks

APRIL 14, 2023

In a news release , the EPA said if its new proposed rules go through, it is estimated they could reduce ethylene oxide emissions from sterilization facilities by 80 percent every year. Medtech companies want to continue serving patients without interruption,” Whitaker said. “We

Regulation 95

Regulation Scientist Manufacturing Cosmetics 95

XTalks

JUNE 12, 2023

3) Johnson & Johnson MedTech 2022 Revenue: The sales of Johnson & Johnson’s MedTech segment were $27.43 2022 Net Income: The net income of Johnson & Johnson MedTech was $4.61 2022 R&D Spend: In 2022, Johnson & Johnson MedTech spent $2.49 billion in 2022, an increase of 1.36 percent from $27.06

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

Delveinsight

SEPTEMBER 15, 2021

Over the past few years, in several stances, news and updates regarding the leakage of health data have been reported by the reported apps manufacturers. In some cases, the data measured with the apps are found to be varying when compared with the MedTech devices. Different apps use different methods and tools to analyze health data.

Doctors 52

Doctors Doctor Marketing Nurses 52

XTalks

OCTOBER 8, 2021

The medtech giant has also expanded another Class I recall of the retainer rings on its 600 series insulin pumps. Medtronic has expanded a Class I recall of remote controllers used with the MiniMed 508 insulin pump or the MiniMed Paradigm family of insulin pumps over potential cybersecurity risks.

Insulin 128

Insulin Life Science Drugs Regulation 128

Pharma Business Blog

FEBRUARY 1, 2022

Swiss Medtech companies have recently engaged national associations in order to take action against the so-called SQS ban by the EU Commission. As a consequence of the failed MRA between CH and the EU, EU certificates (i.e.,

Life Science 52

Life Science Production Manufacturing Medicine 52

Pharma Business Blog

APRIL 13, 2023

We update you on legislation being approved that could impact the companies operating in the MedTech sector in Italy. MedTech Payback was introduced by Law No. 125/2015 for companies operating in the medical device sector that sells medical devices in Italy to the Italian National Healthcare System. 34, 30 March 2023.

Life Science 52

Life Science 52

Pharma Business Blog

FEBRUARY 7, 2023

Photo by Misael Moreno on Unsplash Der Beitrag Fantastic News – EU initiative: Extension of the transition period for medical devices erschien zuerst auf Welcome. Sandra Ragaz, Partner, Leader Pharma & Life Science – International Indirect Tax & Regulatory Sandra.ragaz@pwc.ch

Regulation 52

Regulation In-Vitro Manufacturing Life Science 52

Pharma Business Blog

JULY 27, 2021

With that, as of now Switzerland is considered as a ‘third country’ and Swiss MedTech companies lost their previously barrier-free access to the EU market and vice versa. Until 25 May 2021, all MedTech products that were admitted in Switzerland for sale could also be distributed in the EU and vice versa. How can PwC support you?

Compliance 52

Compliance Regulation Manufacturing Production 52

pharmaphorum

NOVEMBER 2, 2022

billion takeover offer for cardiac pump manufacturer Abiomed looks set to be the largest medtech acquisition of the year, and other buyers are unlikely to enter a bidding war for the business. “We have committed to enhancing our position in medtech by entering high-growth segments.” Johnson & Johnson’s $16.6

Sales 52

Sales Manufacturing Marketing 52

Pharma Business Blog

MAY 10, 2021

Until 25th May 2021 all Medtech products that are admitted in Switzerland for the sale can be distributed also in the EU. However, currently a new treaty is negotiated by Switzerland and the EU Joint Committee in that regard. • What does it mean for Swiss established Medtech companies? Appointment of a new EU resp.

Sales 52

Sales Production Life Science Regulation 52

Delveinsight

SEPTEMBER 2, 2021

FDA awards Breakthrough Device Designation to Impella ECP.

Marketing 72

Marketing Radiology Drugs Drug Delivery 72

Delveinsight

AUGUST 3, 2021

Nevro Received FDA Approval of its 10 kHz High-Frequency Spinal Cord Stimulation Therapy for Treatment of Chronic Pain Associated with Painful Diabetic Neuropathy. On July 19, 2021, Nevro Corp. received approval for its Senza System, Nevro’s unique 10 kHz stimulation, to treat chronic pain associated with Painful Diabetic Neuropathy (PDN).

FDA Approval 98

FDA Approval Marketing Cardiology Production 98

The Pharma Data

MARCH 20, 2021

Choosing the Topic Sometimes there is an obvious choice of content topic– perhaps recent legislation affecting the target audience has caused a stir in the news. Some of our products, such as Scrip, Pink Sheet, and Medtech Insight, have been in the industry for decades and are recognized for their marketleading information worldwide.

Development 52

Development Marketing Branding Contract Manufacturing 52

Delveinsight

SEPTEMBER 30, 2021

RETINA-AI Health, Inc. declares positive pivotal study results for the RETINA-AI Galaxy autonomous Diabetic Retinopathy screening device. On September 20, 2021, RETINA-AI Health, Inc.

FDA Approval 83

FDA Approval Marketing In-Vitro Drugs 83

Delveinsight

AUGUST 19, 2021

Boston Scientific starts recruitment for randomized controlled trials for the EkoSonic Endovascular System.

Marketing 93

Marketing Doctors Doctor Production 93

The Pharma Data

MAY 5, 2021

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. . cases, vaccinations continue to drop as White House sets new inoculation goal ( CNBC ). Medtech. AI, digital health feature in latest batch of FDA breakthrough device designations ( MedTech Dive ).

Vaccination 52

Vaccination Vaccine Gene Therapy Contract Packaging 52

The Pharma Data

MAY 6, 2021

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. . India Covid: Government says new variant linked to surge ( BBC ). Medtech. Posted 06 May 2021 | By Michael Mezher . In Focus: US. Moderna lifts COVID-19 vaccine sales forecast to $19.2 Reps.

Sales 52

Sales Vaccination Vaccine Gene Therapy 52

The Pharma Data

MAY 14, 2021

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. . Scynexis takes out $60M loan ahead of expected approval; Compass Therapeutics acquires new bispecific antibody in buyout ( Endpoints ). Medtech. Posted 14 May 2021 | By Michael Mezher . In Focus: US.

Gene Therapy 52

Gene Therapy Gene Vaccination Vaccine 52

The Pharma Data

MAY 4, 2021

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. . Brazil looks to new Pfizer contract to speed up vaccinations ( Reuters ). Lilly’s Covid-19 partner AbCellera is taking a new antibody into the clinic in the hopes it can tackle all variants ( Endpoints ).

Vaccination 52

Vaccination Vaccine FDA Approval Regulation 52

Delveinsight

JULY 20, 2021

The utility of Trublood®-Prostate clearly demonstrates the potential of CETAC-based technology for the early detection of multiple other cancer types with implications in cancer diagnosis and screening” The post MedTech Wrap Up appeared first on DelveInsight Business Research.

FDA Approval 96

FDA Approval Marketing Trials Gene 96

The Pharma Data

MAY 3, 2021

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. . An FDA official who led the approval of OxyContin got a $400,000 gig at Purdue Pharma a year later, a new book reveals ( BI ). Medtech. Medtech. Posted 03 May 2021 | By Michael Mezher .

Gene Therapy 52

Gene Therapy Vaccination Vaccine Bioequivalency 52

The Pharma Data

MAY 17, 2021

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. . valuation — reveals a few secrets as Matt Gline positions the company as the new ‘Big Pharma’ ( Endpoints ). Medtech. Posted 17 May 2021 | By Michael Mezher . In Focus: US. Now they fear an increase.

Trials 52

Trials Vaccination Vaccine Scientist 52